Ingenus Pharms Llc Company Profile
What is the competitive landscape for INGENUS PHARMS LLC
INGENUS PHARMS LLC has sixty approved drugs.
Summary for Ingenus Pharms Llc
| US Patents: | 0 |
| Tradenames: | 58 |
| Ingredients: | 58 |
| NDAs: | 60 |
Drugs and US Patents for Ingenus Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingenus Pharms Llc | LEUCOVORIN CALCIUM | leucovorin calcium | TABLET;ORAL | 211132-001 | Jul 30, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ingenus Pharms Llc | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 206935-001 | May 26, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ingenus Pharms Llc | DESIPRAMINE HYDROCHLORIDE | desipramine hydrochloride | TABLET;ORAL | 204963-002 | Dec 26, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ingenus Pharms Llc | PANTOPRAZOLE SODIUM | pantoprazole sodium | TABLET, DELAYED RELEASE;ORAL | 211368-001 | Mar 1, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
